Roquefort Therapeutics is a Main Market listed biotech company developing products through the pre-clinical phase prior to partnering or selling to big pharma. The Company’s wholly owned subsidiary, Lyramid Pty Ltd (LYRAMID), is a pre-clinical biotech company focused on developing first in class Midkine inhibiting nucleic acid-based drugs for the treatment of cancer, chronic inflammatory, autoimmune disorder and COVID-19.
Hi Bob,
What is the ticker name please?
It’s LON:ROQ